From left: Philip Tagboto, Country Manager, Sanofi Ghana; Dr Desire Delsol-Gyan, Consultant Cardiologist, Korle-Bu Teaching Hospital, Accra, Ghana; Prof Michael Osom Mate Kole, Consultant Nephrologist, Korle-bu Teaching Hospital, Accra, Ghana; Dr Fifen Inoussa, Director Medical and Regulatory Affairs, Sanofi Nigeria-Ghana; Dr Dwomoah Adu, Consultant Nephrologist, Korle-Bu Teaching Hospital, Accra, Ghana and Folake Odediran, Director, Ethical Business Unit, Sanofi Nigeria-Ghana
SANOFI Ghana, a global healthcare leader in patients needs, says it is reinforcing its commitment to hypertension management through the introduction of APROVASC®.
Aprovasc is a fixed-dose combination therapy (irbesartan/amlodipine) with proven cardiovascular and renal protection benefits and manufactured to highest international standards.
With the introduction of APROVASC®, a fixed-dose combination treatment for the management of hypertension, Sanofi reinforces its sustained commitment to healthcare through the provision of affordable medicines that are tailored to the needs of patients.
A news release issued in Accra by Sanofi Ghana said, “With APROVASC®, Sanofi now offers a wide range of treatment options for patients with hypertension. Sanofi will support its access to healthcare ambitions with the opening of diabetes and hypertension clinics in partnership with health authorities.”
The release said in Ghana, it is estimated that about 28.3 percent of the urban population in adult aged 18-65 years may have hypertension1, adding, “People with uncontrolled hypertension are exposed to many complications including stroke, heart attack, kidney failure and problems with vision, which can be controlled by adopting healthy diets, lifestyle changes and, in many cases, treatment with medications.”
“With over 90 years’ experience in development and manufacturing, Sanofi is a world leader in delivering quality, innovative solutions to meet the needs of patients. The APROVASC® range offers dosage flexibility that allows for individualised treatment,” it said.